Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+2.40%)
As of: Oct 1, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Accounts Payables (2010 - 2026)

Updated

Theriva Biologics' Accounts Payables came in at $984,000 for Q2 2026, up 62.1% from $607,000 a year earlier and up 61.8% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Accounts Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, Theriva Biologics' Accounts Payables was $1.01 million, up 18.0% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $859,000 in FY2024 (+11.6%), $770,000 in FY2023 (-15.8%), $915,000 in FY2022 (+74.6%) and $524,000 in FY2021 (-40.9%).
  • The five-year range for quarterly Accounts Payables is $437,000 (Q1 2025) to $1.35 million (Q1 2022).
  • Year-over-year, Accounts Payables has increased for four consecutive quarters, with growth averaging 8.5% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q1 2022 (growth of 118.0%), and the weakest in Q1 2023 (a decline of 64.5%).
  • Business Quant data shows TOVX's Accounts Payables at $608,000 (Q1 2026), $1.01 million (Q4 2025) and $795,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Theriva Biologics 10.56 Mn 10.56 Mn - 984,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 984,000.00
Mar 31, 2026 608,000.00
Dec 31, 2025 1.01 Mn
Sep 30, 2025 795,000.00
Jun 30, 2025 607,000.00
Mar 31, 2025 437,000.00
Dec 31, 2024 859,000.00
Sep 30, 2024 756,000.00
Jun 30, 2024 935,000.00
Mar 31, 2024 571,000.00
Dec 31, 2023 770,000.00
Sep 30, 2023 833,000.00
Jun 30, 2023 741,000.00
Mar 31, 2023 480,000.00
Dec 31, 2022 915,000.00
Sep 30, 2022 770,000.00
Jun 30, 2022 1.00 Mn
Mar 31, 2022 1.35 Mn
Dec 31, 2021 524,000.00
Sep 30, 2021 1.26 Mn
API Access

Theriva Biologics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TOVX&period=max&api_key=YOUR_API_KEY